fda compounding semaglutide enforcement november 2025 Diabetes advocacy group discourages use of compounded GLP-1 drugs fda semaglutide compounding enforcement november

It may also increase the risk of hypoglycaemia when taken alongside sulphonylureas or insulin, so your prescribing clinician should review your full medication list before and during treatment

We were surprised to find there were no major differences in revascularization or in-stent restenosis despite our initial inclination that GLP-1RAs may reduce incidences of these cardiovascular events, said Moses Sghayyer, MD, Tinsley Harrison Internal Medicine resident at the University of Alabama at Birmingham in Birmingham, Ala., and lead author of the study

This limitation led researchers to explore therapies targeting multiple metabolic pathways

Can GLP-1 medication be shipped to my door